Bernard J. Cassidy, General Counsel & Secretary at Juno Therapeutics, Inc. (JUNO), sold 56,000 shares at $44.67 ($2.5M) on 2017-09-14, disclosed to the SEC on 2017-09-14.
Open-market sale of $2.5M JUNO by General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.67 | 23,054 | $1.0M | 40.9% |
| 2 | $44.67 | 23,054 | $1.0M | 40.9% |
| 3 | $45.90 | 3,441 | $158K | 6.3% |
| 4 | $45.90 | 3,441 | $158K | 6.3% |
| 5 | $46.58 | 1,505 | $70K | 2.8% |
| 6 | $46.58 | 1,505 |
| $70K |
| 2.8% |
| Total | $44.92 avg | 56,000 | $2.5M | 100% |
| Filing → |
| JUNO | SELL | 2016-03-18 | $244K | — | Filing → |
| JUNO | SELL | 2016-02-19 | $214K | — | Filing → |
| JUNO | SELL | 2016-01-20 | $107K | — | Filing → |